BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26596190)

  • 1. Sociodemographic Disparities in the Nonoperative Management of Small Renal Masses.
    Trudeau V; Larcher A; Sun M; Boehm K; Dell'Oglio P; Meskawi M; Sosa J; Tian Z; Fossati N; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2016 Apr; 14(2):e177-82. PubMed ID: 26596190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
    Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
    Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study.
    Trudeau V; Larcher A; Boehm K; Dell'Oglio P; Sun M; Tian Z; Briganti A; Shariat SF; Jeldres C; Karakiewicz PI
    Urology; 2016 Mar; 89():63-7. PubMed ID: 26514977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
    Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
    J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of race and gender on the surgical management of the small renal mass.
    Kates M; Whalen MJ; Badalato GM; McKiernan JM
    Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.
    Larcher A; Meskawi M; Valdivieso R; Boehm K; Trudeau V; Tian Z; Fossati N; Dell'Oglio P; Lughezzani G; Buffi N; Sun M; Karakiewicz P
    World J Urol; 2016 Mar; 34(3):383-9. PubMed ID: 26047653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
    Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based assessment of cancer-specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis.
    Larcher A; Trudeau V; Sun M; Boehm K; Meskawi M; Tian Z; Fossati N; Dell'Oglio P; Capitanio U; Briganti A; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2016 Oct; 118(4):541-6. PubMed ID: 26384713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation.
    Bianchi M; Becker A; Abdollah F; Trinh QD; Hansen J; Tian Z; Shariat SF; Perrotte P; Karakiewicz PI; Sun M
    Int J Urol; 2013 Nov; 20(11):1064-71. PubMed ID: 23418921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociodemographic disparities in the treatment of small renal masses.
    Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in treatment and outcome for renal cell cancer among older black and white patients.
    Berndt SI; Carter HB; Schoenberg MP; Newschaffer CJ
    J Clin Oncol; 2007 Aug; 25(24):3589-95. PubMed ID: 17704406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
    Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National treatment trends among older patients with T1-localized renal cell carcinoma.
    Kim SP; Gross CP; Meropol N; Kutikov A; Smaldone MC; Shah ND; Yu JB; Psutka S; Kiechle J; Abouassaly R
    Urol Oncol; 2017 Mar; 35(3):113.e15-113.e21. PubMed ID: 27839926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort.
    Chen VS; Abouassaly R; Gonzalez CM; Kutikov A; Smaldone MC; Meropol NJ; Psutka SP; Williams SB; O'Malley R; Sedlacek HM; Kim SP
    Urol Oncol; 2017 Nov; 35(11):662.e17-662.e21. PubMed ID: 28781110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment management of small renal masses in the 21st century: a paradigm shift.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in the Clinical Management of clinical T1a Renal Cell Carcinoma.
    Metcalf MR; Cheaib JG; Wainger J; Peña VN; Patel HD; Singla N; Pierorazio PM
    Urology; 2021 May; 151():129-137. PubMed ID: 32890618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.